Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1999-03-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.96.6.2982PMID 10077623PMCID PMC15881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production

  1998cited by this paper
• Tumor immunity and autoimmunity induced by immunization with homologous DNA.

  1998cited by this paper
• CD4+ T Cells Prevent Spontaneous Experimental Autoimmune Encephalomyelitis in Anti–Myelin Basic Protein T Cell Receptor Transgenic Mice

  1998cited by this paper
• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

  1998cited by this paper
• CD4+ T cells, but not CD8+ T cells, are required for the development of experimental autoimmune gastritis

  1998cited by this paper
• gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand

  1998cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

  1998cited by this paper
• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

  1998cited by this paper
• Regulatory CD4+ T Cells Expressing Endogenous T Cell Receptor Chains Protect Myelin Basic Protein–specific Transgenic Mice from Spontaneous Autoimmune Encephalomyelitis

  1998cited by this paper
• A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis.

  1997cited by this paper
• Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism.

  1997cited by this paper
• Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100.

  1997cited by this paper
• Requirement of CD4 T cells for skin graft rejection against thymus leukemia (TL) antigen and multiple epitopes on the TL molecule recognized by CD4 T cells.

  1997cited by this paper
• Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma

  1997cited by this paper
• The Th1/Th2 paradigm.

  1997cited by this paper
• Cancer vaccines based on the identification of genes encoding cancer regression antigens.

  1997cited by this paper
• Compact, synthetic, vaccinia virus early/late promoter for protein expression.

  1997cited by this paper
• Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.

  1997cited by this paper
• Tumor antigens recognized by T cells.

  1997cited by this paper
• Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE)

  1996cited by this paper
• T cell selection and autoimmunity: flexibility and tuning.

  1996cited by this paper
• Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.

  1996cited by this paper
• The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.

  1996cited by this paper
• Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

  1996cited by this paper
• CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge

  1996cited by this paper
• Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells

  1996cited by this paper
• Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Requirement of CD4+ T cells and antigen-presenting cells for primary in vitro generation of CD8+ cytotoxic T cells against Ld-binding self-peptide p2Ca.

  1995cited by this paper
• T‐Cell Immunotherapy of Tumors by Adoptive Transfer of Cytotoxic T Lymphocytes and by Vaccination with Minimal Essential Epitopes

  1995cited by this paper
• Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

  1995cited by this paper
• A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

  1995cited by this paper
• Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

  1995cited by this paper
• The tyrosinase gene family--interactions of melanogenic proteins to regulate melanogenesis.

  1994cited by this paper
• The role of tyrosinase in autoimmune vitiligo.

  1994cited by this paper
• Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.

  1994cited by this paper
• A second tyrosinase‐related protein, TRP‐2, maps to and is mutated at the mouse slaty locus.

  1992cited by this paper
• Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice

  1992cited by this paper
• A fail-safe mechanism for maintaining self-tolerance

  1992cited by this paper
• Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.

  1991cited by this paper
• Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice

  1991cited by this paper
• β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells

  1990cited by this paper
• Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes.

  1990cited by this paper
• Antibodies to normal human melanocytes in vitiligo

  1983cited by this paper
• Immunity to methylcholanthrene-induced sarcomas.

  1957cited by this paper

• The immunology of vitiligo.

  2026cites this paper
• The relativity of regulatory T cell suppression modes.

  2026cites this paper
• The Efficacy of Neoantigen-Loaded Dendritic Cell Vaccine Immunotherapy in Non-Metastatic Gastric Cancer

  2025cites this paper
• Reconfiguring the immune system to target cancer: Therapies based on T cells, cytokines, and vaccines.

  2025cites this paper
• Deciphering Depigmentation: Mouse Models for Vitiligo Research.

  2025cites this paper
• Animal models unraveling the complexity of vitiligo pathogenesis.

  2024cites this paper
• Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center

  2024cites this paper
• Application of Viruses for Gene Therapy and Vaccine Development

  2022cites this paper
• MVAΔ008 viral vector encoding the model protein OVA induces improved immune response against the heterologous antigen and equal levels of protection in a mice tumor model than the conventional MVA.

  2021cites this paper
• Beneficial autoimmunity improves cancer prognosis

  2021cites this paper
• Characterization of tyrosinase and selected autoantibodies in Chinese vitiligo patients

  2021cites this paper
• Immunology of Melanoma

  2020cites this paper
• Default polyfunctional T helper 1 response to ample signal 1 alone

  2020cites this paper
• Default polyfunctional T helper 1 response to ample signal 1 alone

  2020cites this paper
• Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens

  2019cites this paper
• Animal models in disorders of skin color − utilizing evolution and demystifying mysteries

  2019cites this paper
• In Silico Analysis of Ixodid Tick Aqauporin-1 Protein as a Candidate Anti-Tick Vaccine Antigen

  2019cites this paper
• Animal Models

  2019cites this paper
• Inosine is an alternative carbon supply that supports effector T cell proliferation and antitumor function under glucose restriction

  2019cites this paper
• Identification of Ixodid Tick-Specific Aquaporin-1 Potential Anti-tick Vaccine Epitopes: An in-silico Analysis

  2019cites this paper
• Vitiligo

  2019cites this paper
• Investigation of cytomegalovirus-based cancer vaccines

  2018cites this paper
• A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses

  2018cites this paper
• Peptide Delivery Systems for Cancer Vaccines

  2018cites this paper
• Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model.

  2018cites this paper
• Mouse Model for Human Vitiligo

  2018cites this paper
• Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain

  2017cites this paper
• Combination immunotherapy: a road map The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

  2017cites this paper
• Combination immunotherapy: a road map

  2017cites this paper
• Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses

  2016cites this paper
• Mouse Models of Tumor Immunotherapy.

  2016cites this paper
• Chapter 147 – Autoimmune Endocrine Disorders∗

  2016cites this paper
• Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?

  2016cites this paper
• Targeting interference of CTLA-4 co-inhibition to tumour specific T cells to enhance activity and reduce toxicity

  2016cites this paper
• Dendritic Cell Control of Immune Responses

  2015cites this paper
• Mouse Model for Pre‐Clinical Study of Human Cancer Immunotherapy

  2015cites this paper
• Cancer vaccines

  2015cites this paper
• Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides.

  2015cites this paper
• Molecular and functional analysis of the tumour antigen T21

  2015cites this paper
• Title Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma

  2015cites this paper
• Targeting cancer with reovirus.

  2015cites this paper
• Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines

  2014cites this paper
• Novel Technologies for Vaccine Development

  2014cites this paper
• Animal models of vitiligo: Matching the model to the question *

  2014cites this paper
• Immunomodulation of malignant melanoma by contact sensitizing agents

  2014cites this paper
• Regulation by IL-10 of innate immune responses to MUC1 as a self-antigen in MUC1 transgenic mice

  2014cites this paper
• Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.

  2014cites this paper
• Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy

  2014cites this paper
• Global Inhibition of DC Priming Capacity in the Spleen of Self-Antigen Vaccinated Mice Requires IL-10

  2014cites this paper
• Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: to use or not to use?

  2014cites this paper
• Direct recognition of tumors by regulatory T-cells with suppression of immune rejection.

  2014cites this paper
• Identification of Pre- and Post-Treatment Markers, Clinical, and Laboratory Parameters Associated with Outcome in Renal Cancer Patients Treated with MVA-5T4

  2013cites this paper
• Recurrence of Melanoma T Cells during + Tumor-Specific CD 4 Restoring Immune Function of Tamada

  2013cites this paper
• Vaccines against advanced melanoma.

  2013cites this paper
• This information is current as Fas-Fas Ligand Interactions Spontaneous Vitiligo and Depends upon a Melanocyte Neoantigen Induces CD4 T Cell-Dependent Autoimmunity against

  2013cites this paper
• Recurrence of Melanoma T Cells during + Tumor-Specific CD4 Restoring Immune Function of

  2013cites this paper
• Research fronts on vitiligo, a Scopus based bibliometric survey Frentes de investigación sobre vitiligo, un enfoque bibliométrico basado en Scopus

  2013cites this paper
• Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma

  2013cites this paper
• How Numbers, Nature, and Immune Status of Foxp3+ Regulatory T-Cells Shape the Early Immunological Events in Tumor Development

  2013cites this paper
• Differentiation of stem and progenitor cells from bone marrow in activated dendritic cells and lymphocytes with anti-malignant properties

  2013cites this paper
• Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation

  2013cites this paper
• Induction of auto-antibodies to Cathepsin B.

  2013cites this paper
• This information is current as HLA-A*0201-Transgenic Mice Control of Melanoma Outgrowth in Tyrosinase and Glycoprotein 100 Enable HLA-A*0201-Restricted Epitopes of Immune Responses to the

  2013cites this paper
• by Tumor-Targeted IL-2 Shift from Systemic to Site-Specific Memory

  2013cites this paper
• Supplemental material for : Simultaneous Targeting of Tumor Antigens and the Tumor Vasculature using T Lymphocyte Transfer Synergize to Induce Regression of Established Tumors in Mice

  2013cites this paper
• T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients

  2013cites this paper
• Innate immune mechanisms in vitiligo: danger from within.

  2013cites this paper
• MAGE-3 Protein in Lung Cancer Patients Vaccine-Induced CD4+ T Cell Responses to

  2013cites this paper
• Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice.

  2013cites this paper
• This information is current as Occurring T Regulatory Cells T Helper Cells and Hindered by Naturally + Tumor/Self-Antigen Is Augmented by CD4 T Cell Immunity Against a + CD8

  2013cites this paper
• Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer

  2012cites this paper
• Gene expression in Sinclair swine with malignant melanoma.

  2012cites this paper
• Targeting Th (Th17 and Th2) suppressive and stimulatory effect on cytotoxic T cells

  2012cites this paper
• CD4+ T cell mediated tumor immunity following transplantation of TRP-1 TCR gene modified hematopoietic stem cells

  2012cites this paper
• Investigation of the activation of tumour-specific immune responses by gene therapy strategies using a model tumour antigen

  2012cites this paper
• Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes

  2012cites this paper
• Adoptive immunotherapy for cancer: harnessing the T cell response

  2012cites this paper
• Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy

  2012cites this paper
• Development and Characterization of Experimental Autoimmune Cystitis (EAC)

  2012cites this paper
• Lentivector based gene transfer for immunotherapy – application of integration deficient vectors and PDL1knockdown as tools to manipulate immune responses

  2012cites this paper
• Exploiting the mutanome for tumor vaccination.

  2012cites this paper
• Innovative Cancer Vaccine Strategies Based on the Identification of Tumour-Associated Antigens

  2012cites this paper
• Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity

  2011cites this paper
• Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo.

  2011cites this paper
• Autoimmunity associated with immunotherapy of cancer.

  2011cites this paper
• Biological circuit models of immune regulatory response: A decentralized control system

  2011cites this paper
• The haptenation theory of vitiligo and melanoma rejection: a close‐up

  2011cites this paper
• Evidence for a Repertoire of Functional Untolerized CD4+ T Cells Specific for Melanoma‐Associated Antigens

  2011cites this paper
• melanoma Tumor-specific Th17-polarized cells eradicate large established

  2011cites this paper
• Development of tools to target antigen through mannose receptor

  2011cites this paper
• Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice

  2011cites this paper
• GILT modulates CD4+ T cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1

  2011cites this paper
• MVA and NYVAC as vaccines against emergent infectious diseases and cancer.

  2011cites this paper
• TRP-1 AS A MODEL TUMOR ANTIGEN FOR IMMUNOTHERAPY AND IMMUNE TOLERANCE IN THE THYMUS

  2011cites this paper
• In Vivo Imaging of an Inducible Oncogenic Tumor Antigen Visualizes Tumor Progression and Predicts CTL Tolerance

  2010cites this paper
• Immunotherapy Can Reject Intracranial Tumor Cells without Damaging the Brain despite Sharing the Target Antigen

  2010cites this paper
• TroVax, a recombinant modified vaccinia Ankara virus encoding 5T4: Lessons learned and future development

  2010cites this paper
• Balb/c EGFP mice are tolerant against immunization utilizing recombinant adenoviral-based vectors encoding EGFP: a novel model for the study of tolerance mechanisms and vaccine efficacy.

  2010cites this paper
• Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity.

  2010cites this paper
• The Immunosuppressive Tumor Environment Is the Major Impediment to Successful Therapeutic Vaccination in Neu Transgenic Mice

  2010cites this paper